What is Edward’s syndrome?
- What is Edwards’ syndrome?
- How common is Edwards’ syndrome?
- What causes Edwards’ syndrome?
- Can HIV cause Edwards’ syndrome?
- What are the different types of Edwards’ syndrome?
- Is Edwards’ syndrome hereditary?
- What can impact the probability of having a child with Edwards’ syndrome?
- What are the characteristics/features/symptoms of Edwards’ syndrome?
- What is the treatment for Edwards’ syndrome?
- How can I get Edwards’ syndrome screening during pregnancy?
This test is a simple blood test with no risk to the mother or the baby, and can be carried out from as early as 10 weeks.
The three most common chromosomal conditions covered by the Standard AlphaBiolabs IONA® test are:
- Down’s syndrome (Trisomy 21)
- Edwards’ syndrome (Trisomy 18)
- Patau’s syndrome (Trisomy 13)
Down’s syndrome is by far the most common chromosomal aneuploidy included in this screening test. As well as Down’s syndrome, the Standard AlphaBiolabs IONA® NIPT test also screens for Edwards’ syndrome, and Patau’s syndrome, which are much more serious than Down’s syndrome – babies born with these conditions rarely survive past infancy.
Additionally, the Advanced AlphaBiolabs NIPT test can also detect all other aneuploidies, including Autosomal Aneuploidies (AAs) and Sex Chromosome Aneuploidies (SCAs) such as Turner’s syndrome, Klinefelter’s syndrome, Jacob’s syndrome and Trisomy X.
In this article, we focus on Trisomy 18, also known as Edwards’ syndrome.
What is Edwards’ syndrome?
Edwards’ syndrome is a very rare but serious chromosomal condition. It is caused by having a full or partial extra copy of chromosome 18 and is sometimes referred to as Trisomy 18.
Sadly, around 70% of Trisomy 18 pregnancies end in miscarriage or stillbirth, and very few babies (13 in 100) survive past their first birthday.
Having a baby with Edwards’ syndrome (an extra copy of chromosome 18) occurs as a result of a change in the egg or sperm, usually before the baby is conceived. This is a random chance event, and even though the risk of having a baby with Edwards’ syndrome increases with age, anyone can have an affected pregnancy.
How common is Edwards’ syndrome?
Edwards’ syndrome is a very serious and rare condition. Around 1 in 400 pregnancies are diagnosed with Edwards’ syndrome. However, the number of live births of babies with Edwards’ syndrome ranges from 1 in 3,600 to 1 in 10,000 and is dependent on the country and its termination policies. Therefore, very few pregnancies affected by Edwards’ syndrome result in live birth. This is because around 70% of affected pregnancies end in miscarriage or stillbirth, and very few live births (13%) survive past one year.
What causes Edwards’ syndrome?
Edwards’ syndrome is caused by having an extra critical portion of chromosome 18. This imbalance of chromosomes can be present in all or some cells that make up the body. Passing on an extra copy of chromosome 18 occurs by random chance, and even though we know that the likelihood of having a baby with Edwards’ syndrome increases with age, anyone can have an affected pregnancy. In most cases, Edwards’ syndrome is not hereditary and does not run in families.
Can HIV cause Edwards’ syndrome?
HIV does not affect the risk of having a pregnancy affected by Edwards’ syndrome. Edwards’ syndrome is most often caused by a chance event that occurs in the egg or sperm before fertilisation. Even though the risk increases with age, it is not caused by anything that either parent did before or during pregnancy.
What are the different types of Edwards’ syndrome?
If a baby has Edwards’ syndrome, they inherited a full or partial extra copy of chromosome 18, which can be present in all or some of their cells. More than 90% of Edwards’ syndrome instances are caused by Trisomy 18 (having an extra full copy of chromosome 18 in all cells). The remaining 10% of cases are caused by one of two rare genetic occurrences.
The full form (trisomy 18) is the most common and most severe type of Edwards’ syndrome and occurs when a person has a full, separate, extra copy of chromosome 18. It accounts for over 90% of all Edwards’ syndrome cases.
Around 5% of babies born with Edwards’ syndrome will have a less severe form, known as mosaic Edwards’ syndrome. These individuals will have an extra copy of chromosome 18 in some, but not all of the cells in their body.
The remaining cases of Edwards’ syndrome are caused by having an extra portion of chromosome 18, rather than an entire extra chromosome. This is an incredibly rare form of Edwards’ syndrome.
Is Edwards’ syndrome hereditary?
Edwards’ syndrome does not usually run in families and is therefore not hereditary. However, in very rare instances, Edwards’ syndrome has a hereditary component, meaning that it has been passed on from a parent to a child through genes.
What can impact the probability of having a child with Edwards’ syndrome?
The risk of having a pregnancy affected by Edwards’ syndrome increases with maternal age. This means that older women have an increased chance of having a baby with Edwards’ syndrome.
However, the majority of cases of Edwards’ syndrome are caused by a random event that occurs within the egg or sperm prior to conception. This means that anyone can have a baby with Edwards’ syndrome.
In very rare cases, healthy individuals who carry a balanced chromosomal translocation can be at an increased risk of having a pregnancy affected by Edwards’ syndrome.
What are the characteristics/features/symptoms of Edwards’ syndrome?
Edwards’ syndrome is a very serious condition. Over 70% of Edwards’ syndrome pregnancies result in miscarriage or stillbirth and only 13% of babies that are born survive past their first birthday.
All babies born with Edwards’ syndrome will have a level of learning disability, which is often very severe, and many health challenges.
Usually, babies with Edwards’ syndrome will have a low birthweight and problems with feeding and breathing. Health complications include respiratory, heart, kidney, and digestive problems.
Even though survival is rare, babies born with full Edwards’ syndrome can slowly make progress in their development. Babies born with partial or mosaic Edwards’ syndromes often have a better prognosis and can have an increased life expectancy, despite their complex physical and mental needs.
What is the treatment for Edwards’ syndrome?
There is no cure for Edwards’ syndrome. Babies born with Edwards’ syndrome have a poor prognosis and survival past one year is rare. Treatments are based on each individual’s medical, developmental and intellectual needs. Babies born with Edwards’ syndrome often have difficulty feeding, and may be fed through a feeding tube.
How can I get Edwards’ syndrome screening during pregnancy?
A screening test for Down’s syndrome, Edwards’ syndrome and Patau’s syndrome is often available at 10-14 weeks of pregnancy. The screening test that is most widely available is known as a ‘combined’ test.
The combined test comprises of a blood test and an ultrasound scan. The blood test looks at markers found in the blood that can indicate an increased chance of carrying a baby with a chromosomal disorder. The ultrasound scan is used to determine something known as the ‘nuchal translucency’.
The results of both of these tests are used along with the age of the pregnant woman to determine the risk of carrying a foetus with Down’s syndrome, Edwards’ syndrome or Patau’s syndrome.
In the case of a high-risk result from the combined test, the pregnant woman will be offered the chance to receive NIPT, which is another screening test, or diagnostic testing, which may be an amniocentesis or chorionic villus sampling (CVS). Amniocentesis and CVS will provide a definite answer as to whether or not the baby has Down’s syndrome, Patau’s syndrome or Edwards’ syndrome, but in rare cases amniocentesis and CVS can cause a miscarriage.
Therefore, many pregnant people are choosing to take a NIPT screening test privately, as it is available to all expectant mothers, irrespective of whether they were classified as high risk by the combined test.
To perform CVS or amniocentesis, foetal DNA must be obtained for analysis. Foetal DNA is traditionally acquired through invasive sampling methods. Amniocentesis involves a long, thin needle that is inserted through the abdomen (stomach) to obtain a sample for testing. For CVS, a needle is inserted into the womb to obtain a sample of cells. Both procedures are invasive and increase the risk of pregnancy loss. The increased risk of miscarriage is often a dilemma, and many pregnant women therefore opt for NIPT as their initial screening test.
The AlphaBiolabs IONA® NIPT test only requires a simple blood sample, which can be provided from 10+ weeks’ gestation by any expectant mother, not just those who received a high-risk result from the combined test. The AlphaBiolabs NIPT test is a laboratory test which detects 97.2%-100% of trisomies in singleton and twin pregnancies. The AlphaBiolabs IONA® NIPT test can also provide foetal sex determination, which is not offered by the NHS. With results available in just 7 working days, you can get results much faster than the traditional testing pathway.
Traditional screening consists of multiple tests across the first and second trimesters, which can detect around 85% of babies with Down’s syndrome, and 80% of babies with Edwards’ or Patau’s syndrome.
|Traditional Screening Tests||AlphaBiolabs IONA® NIPT|
|Multiple procedures over the course of the first and/or second trimester||One laboratory test at any time over 10 weeks gestation|
|Combined screening identifies around 85% of babies with Down’s syndrome and 80% of babies with Edwards’ or Patau’s syndrome||The AlphaBiolabs IONA® NIPT test detects >99.9% of babies with Down’s syndrome, Edward’s syndrome and Patau’s syndrome|
|Reduced performance of screening in twin pregnancies||Equivalent performance of screening in both twin and singleton pregnancies|
|Results are provided following several tests, which can take some time||Results provided within 5-7 working days|
|Can involve invasive methods that can harm the mother and baby and carry an increased chance of miscarriage||Blood test taken from mother’s arm, posing no risk to mother or baby|
|No gender identification||Gender identification available|
|Tests for Down’s syndrome, Edward’s syndrome and Patau’s syndrome only||Can look for chromosomal changes in all 46 chromosomes|
|NIPT if offered only to pregnancies determined as ‘high-risk’ by the combined test||Can be taken by any pregnant person, irrespective of the risk status determined by the combined test|
Order your NIPT
Order your Non‑invasive Prenatal Genetic Test online from an award-wining laboratory.
Health Testing Specialist at AlphaBiolabs
Karolina joined AlphaBiolabs in 2021, and holds the role of Health Testing Specialist.
As well as overseeing a range of health tests, Karolina plays an active role in the research and development of the company’s latest health test offerings.
Before joining AlphaBiolabs, Karolina worked as an Associate Practitioner at Mid-Cheshire Hospitals NHS Foundation Trust, and as a research assistant at the Turner Laboratory, within the Faculty of Biology, Medicine and Health at The University of Manchester.
Karolina’s main scientific interests include clinical genomics and genetic diagnostics. Her qualifications include a BSc in Molecular Biology and an MSc in Genomic Medicine.
An NIPT is a genetic test used to screen for genetic abnormalities during pregnancy. Find out more in our expert article.
In this article we look at what Down’s syndrome is, the causes and characteristics of Down’s syndrome, and how you can test for Down’s syndrome before birth.